Experimental therapies

Instytut Terapii Komórkowych (the Cell Therapies Institute) is a medical entity specialised in an innovative therapy in which use is made ofmesenchymal stem cells. The Therapy has the nature of a medi...cal treatment experiment. It is dedicated to adult patients with Amyothropic Lateral Sclerosis, Secondary Progressive Multiple Sclerosis and rare neurodegenerative diseases. The Therapy is conducted pursuant to the permit granted by the Bioethical Commission of the Warmia and Masuria University.
The Institute has its seat in Olsztyn and commenced in operation in September 2014. First Patients were taken in to the Ward in April 2016.

Our objectives:

Treatment of Patients
Confirmation of safety and effectiveness of use ofmesenchymal stem cellsin the given disease entity
Development of a new treatment method.

In KLARA Medical Center in Częstochowa mesenchymal cells (MSCs) from Wharton's jelly are applied in medical experiments to help treat neurological and opthtalmologistic patients.

In Klinika Hematologii, Onkologii i Transplantologii Dziecięcej in Lublin mesenchymal cells (MSCs) from Wharton's jelly are applied in medical experiments to help treat neurological patients.

In private hospital RegenMed in Kraków mesenchymal cells (MSCs) from Wharton's jelly are applied in medical experiments to help treat neurological patients.

In Szpital Okulistyczny Retina ( Retina Eye Hospital) in Warszawiemesenchymal cells (MSCs) from Wharton's jelly are applied in medical experiments to help treat opthtalmologistic patients.

The medical manager of the team is prof. dr hab. med. Krzysztof Selmaj one of the most experienced Polish neurologists, and with many years of experience working in England and the USA. Former preside...nt of Poland for the Neurological Society and vice president of the European Neurological Society.
We deal with all neurological diseases.

In Klinika Zdrowej Kości ( Healthy Bone Clinic) in Łódz mesenchymal cells (MSCs) from Wharton's jelly are applied in medical experiments to help treat orthopedic patients.

In Samodzielnym Publicznym Szpitalu Klinicznym nr 4 (Independent Public Hospital no. 4) in Lublin mesenchymal cells (MSCs) from Wharton's jelly are applied in medical experiments to help treat orthope...dic patients.

ŻAGIEL MED is a modern medical center, offering patients not only high standards of service, but also respect for the rights of a patient. Treating our patients is our passion. We believe that a smile... and positive relationships strongly support the healing process. In ŻAGIEL MED, mesenchymal cells (MSCs) from Wharton's jelly are applied in medical experiments to help treat neurological patients.

In NZOZ Przyjaciel in Kielce, mesenchymal cells (MSCs) from Wharton's jelly are applied in medical experiments to help treat orthopedic patients.

Provincial Specialist Hospital in Wrocław The Research and Development Center is a multidisciplinary medical unit with its own and unique scientific facilities in the country, in the form of an Early-...Development Research Center. It is classified by the Ministry of Science and Higher Education and currently has a category A. The center consists of three subunits specialized in the following disciplines: Robotic Surgery Center, the first and still only in Poland, the Clinical Research Center and the Scientific Laboratory, designed to effectively support the treatment process through participation in the development of new diagnostic methods and therapies.

In Głogowski Szpital Powiatowy, mesenchymal cells (MSCs) from Wharton's jelly are applied in medical experiments to help treat orthopedic patients.

ORTHOS Hospital is a modern medical facility in Komorowice near Wrocław, in which patients benefit from the highest standards of diagnostics, treatment and rehabilitation. The scope of services provid...ed includes, among others innovative orthopedic treatments (including treatment using stem cells and platelet-rich plasma), plastic surgery and general surgery, ENT, oncology, gynecology and neurosurgery. The hospital also conducts specialized rehabilitation stays dedicated to patients after knee or hip joint replacement surgery and people after injuries. At Orthos Hospital, mesenchymal stem cells from Wharton's jelly are administered to patients with orthopedic diseases.